vaccine therapy

BIOLOGICAL4 trials

Sponsors

Jonsson Comprehensive Cancer Center, Favrille, M.D. Anderson Cancer Center, Emory University

Conditions

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8

Early Phase 1

Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma

CompletedNCT03631043

M.D. Anderson Cancer CenterSmoldering Plasma Cell Myeloma

Start: 2018-12-21End: 2025-12-10Updated: 2025-12-19

Phase 1

Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

TerminatedNCT00098917

Jonsson Comprehensive Cancer CenterLung Cancer

Start: 2005-02-28Target: 15Updated: 2008-01-28

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

RecruitingNCT06324240

Emory UniversityAnatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 +24

Start: 2025-12-02End: 2026-12-31Target: 18Updated: 2026-01-26

Phase 3

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

SuspendedNCT00324831

FavrilleLymphoma

Target: 480Updated: 2013-12-18